masoprocol and Inappropriate GH Secretion Syndrome (Acromegaly)

masoprocol has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanew, K; Ikeda, H; Tanaka, A; Utsumi, A; Yokogoshi, Y1

Other Studies

1 other study(ies) available for masoprocol and Inappropriate GH Secretion Syndrome (Acromegaly)

ArticleYear
Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:10

    Topics: Acromegaly; Adenoma; Adult; Colforsin; Drug Combinations; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Masoprocol; Middle Aged; Oligopeptides; Pituitary Neoplasms; Tetradecanoylphorbol Acetate; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured

1998